Identification of a naturally processed cyclin D1 T-helper epitope by a novel combination of HLA class II targeting and differential mass spectromotry. Dengjel J*, Decker P*, Schoor O, Altenberend F, Weinschenk T, Rammensee HG, Stevanovic S. Eur J Immunol, 2004, 34:3644-51. *The first two authors contributed equally to this work.
TNF-a antibodies and osteoprotegerin decrease systemic bonne loss-associated with inflammation through distinct mechanisms in collagen-induced arthritis. Saidenberg-Kermanac’h N, Corrado A, Lemeiter D, de Vernejoul MC, Boissier MC, Cohen-Solal M. Bone, 2004, 35:1200-7
Gene therapy of collagen-induced arthritis by electrotransfer of human tumor necrosis factor-alpha soluble receptor I variants. Bessis N*, Bloquel N*, Boissier MC, Scherman D, Bigey P. Hum Gene Ther 2004 ; 15 : 189-201
Effect of Synovial Fluid on Adeno-Associated Virus-Mediated Gene Transfer to Chondrocytes. Cottard V, Valvasson C, Falgarone G, Lutomski D, Boissier MC, Bessis N J Clin Immunol, 2004, 24 : 162-9
IgG reactivity with a 100 kDa tissue and endothelial cell antigen identified as topoisomerase 1 distinguishes between limited abd diffuse systemic sclerosis patients. Garcia de la Pena-Lefebvre P, Chanseaud Y, Tamby MC, Reinbolt J, Batteux F, Allanore Y, Kahan A, Meyer O, Benveniste O, Boyer O, Guillevin L, Boissier MC, Mouthon L. Clin Immunol 2004, 11:241-51
Survey of Practices Regarding Management of Early Typical Rheumatoid Arthritis by Rheumatologists in France. Maravic M, Bergé C, Daurès JP, Boissier MC , Clin Exp Rheumatol, 2004, 22:319-27
Osteoprotegerin and interleukin-4 cellular gene therapy decrease bone resorption-associated inflammation in collagen-induced arthritis. Saidenberg-Kermanac’h N, Bessis N, Lemeiter D, de Vernejoul MC, Boissier MC, Cohen-Solal M. . J Clin Immunol, 2004, 24 :370-8